Circulating miR-29a and miR-150 correlate with delivered dose during thoracic radiation therapy for non-small cell lung cancer

Table 1 Patient characteristics of profiling cohort

Patient	Age/Gender	Diagnosis	Indication/Type of treatment	Chemotherapy	RT dose
2468	76/F	IIIA SCC	definitive	KT	60.0 Gy
2510	61/F	IIIA ADENO	definitive	EP	66.0 Gy
2526	60/M	IIIA ADENO	neoadjuvant	EP	54.0 Gy
2534	60/F	IIIA SCC	definitive	EP	66.0 Gy
2561	76/M	IIIA ADENO	definitive	KT	66.0 Gy

Abbreviations: SCC squamous cell carcinoma, ADENO adenocarcinoma, KT carboplatin/paclitaxel, EP, etoposide/cisplatin

ISSN: 1748-717X